Midodrine for the Treatment of Refractory Hypotension
This study is currently recruiting participants.
Verified February 2017 by Matthias Eikermann, Massachusetts General Hospital
Massachusetts General Hospital
First Posted: February 13, 2012
Last Update Posted: February 27, 2017
Sir Charles Gairdner Hospital
Information provided by (Responsible Party):
Matthias Eikermann, Massachusetts General Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||December 2017|
|Estimated Primary Completion Date:||December 2017 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Anstey MH, Wibrow B, Thevathasan T, Roberts B, Chhangani K, Ng PY, Levine A, DiBiasio A, Sarge T, Eikermann M. Midodrine as adjunctive support for treatment of refractory hypotension in the intensive care unit: a multicenter, randomized, placebo controlled trial (the MIDAS trial). BMC Anesthesiol. 2017 Mar 21;17(1):47. doi: 10.1186/s12871-017-0339-x.